← Back
$AVTX All transactions

Avalo Therapeutics, Inc.

M

$ Value

$0

Shares

64,866

Price

$0

Filed

Mar 31

Insider

Name

NEIL GARRY ARTHUR

Title

Chief Executive Officer

CIK

0001586785

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-28

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

64,867

Footnotes

Restricted stock units convert into common stock on a one-for-one basis. | On August 13, 2024, the Reporting Person was granted 194,600 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date.

Filing Info

Accession No.

0001586785-26-000004

Form Type

4

Issuer CIK

0001534120

NEIL GARRY ARTHUR's History

Date Ticker Type Value
2026-03-28 AVTX M
2026-03-28 AVTX F $304K
2026-03-28 AVTX M $0
2025-06-05 CLDX A $0

Other Insiders at AVTX (90d)

Insider Bought Sold Last
KAPLAN GILLA 2026-03-28
NEIL GARRY ARTHUR
Chief Executive Officer
2026-03-28
Lind Kevin Robert 2026-03-31
Jain Rita 2026-03-31
Chan Mitchell 2026-03-28
Sullivan Christopher Ryan
Chief Financial Officer
$271K 2026-04-02
KANTOFF AARON 2026-03-28
Doyle Mittie
Chief Medical Officer
$82K 2026-04-06
Goldman Jonathan 2026-03-28
Truex Samantha 2026-03-28